These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27077070)

  • 21. [Latent tuberculosis infection screening in healthcare workers in four large hospitals in Santiago, Chile].
    Hernández M; Casar C; García P; Morales V; Mamani N; Gómez-Cofré N; Pizarro P; Balcells ME
    Rev Chilena Infectol; 2014 Jun; 31(3):254-60. PubMed ID: 25146198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a guinea pig model of latent tuberculosis with GFP-introduced Mycobacterium tuberculosis.
    Sugawara I; Udagawa T; Aoki T; Mizuno S
    Tohoku J Exp Med; 2009 Nov; 219(3):257-62. PubMed ID: 19851055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New tuberculosis therapeutics: a growing pipeline.
    Spigelman MK
    J Infect Dis; 2007 Aug; 196 Suppl 1():S28-34. PubMed ID: 17624823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care workers and the initiation of treatment for latent tuberculosis infection.
    Gershon AS; McGeer A; Bayoumi AM; Raboud J; Yang J
    Clin Infect Dis; 2004 Sep; 39(5):667-72. PubMed ID: 15356781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of latent tuberculosis infection and smear positive pulmonary tuberculosis in people with household close contact with tuberculosis in north of iran.
    Moosazadeh M; Khanjani N; Parsaee M
    Iran J Med Sci; 2015 Mar; 40(2):161-5. PubMed ID: 25821296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.
    LoBue PA; Mermin JH
    Lancet Infect Dis; 2017 Oct; 17(10):e327-e333. PubMed ID: 28495525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection.
    Tufariello JM; Chan J; Flynn JL
    Lancet Infect Dis; 2003 Sep; 3(9):578-90. PubMed ID: 12954564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis.
    Barry CE; Boshoff HI; Dowd CS
    Curr Pharm Des; 2004; 10(26):3239-62. PubMed ID: 15544513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection.
    Wang C; Lu J; Du W; Wang G; Li X; Shen X; Su C; Yang L; Chen B; Wang J; Xu M
    Vaccine; 2019 Jul; 37(32):4477-4484. PubMed ID: 31266673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation of latent tuberculosis: variations on the Cornell murine model.
    Scanga CA; Mohan VP; Joseph H; Yu K; Chan J; Flynn JL
    Infect Immun; 1999 Sep; 67(9):4531-8. PubMed ID: 10456896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro models of Mycobacterium tuberculosis dormancy, and in vivo models of latent tuberculosis infection.].
    Fursov MV; Dyatlov IA; Potapov VD
    Klin Lab Diagn; 2019; 64(5):299-307. PubMed ID: 31185154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis.
    Ferguson TW; Tangri N; Macdonald K; Hiebert B; Rigatto C; Sood MM; Shaw S; Lerner B; Xu Y; Mahmud S; Komenda P
    Transplantation; 2015 May; 99(5):1084-91. PubMed ID: 25286055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
    Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
    Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States.
    Khan K; Muennig P; Behta M; Zivin JG
    N Engl J Med; 2002 Dec; 347(23):1850-9. PubMed ID: 12466510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials.
    Campbell JR; Trajman A; Cook VJ; Johnston JC; Adjobimey M; Ruslami R; Eisenbeis L; Fregonese F; Valiquette C; Benedetti A; Menzies D
    Lancet Infect Dis; 2020 Mar; 20(3):318-329. PubMed ID: 31866327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Etanercept and infection - latent tuberculosis].
    González-Sixto B; Rodríguez-Prieto MA
    Actas Dermosifiliogr; 2010 May; 101 Suppl 1():62-9. PubMed ID: 20492883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of latent tuberculosis infection.
    Parekh MJ; Schluger NW
    Ther Adv Respir Dis; 2013 Dec; 7(6):351-6. PubMed ID: 24056289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.
    Doherty SD; Van Voorhees A; Lebwohl MG; Korman NJ; Young MS; Hsu S; National Psoriasis Foundation
    J Am Acad Dermatol; 2008 Aug; 59(2):209-17. PubMed ID: 18485527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis Infection and Latent Tuberculosis.
    Lee SH
    Tuberc Respir Dis (Seoul); 2016 Oct; 79(4):201-206. PubMed ID: 27790271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of specific reductases in the intracellular activation and binding of 2-nitroimidazoles.
    Joseph P; Jaiswal AK; Stobbe CC; Chapman JD
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):351-5. PubMed ID: 8195032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.